The company supports early-phase product development, process validation, and OEM and clinical batch production of implantable medical devices.
The company helps entrepreneurs with cost-price, market, and competitive-landscape analyses and business-plan writing.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company has experience and a network in using supercritical CO2 technology to decellularize and sterilize animal and human tissues in accordance with CE/FDA requirements.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 20, 2026, September 26, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.